Skip to main content
Signal8

ProQR Therapeutics N.V. (PRQR)

ProQR Therapeutics N.V. operates as a biopharmaceutical enterprise dedicated to discovering and developing RNA-based therapies designed to address genetic disorders. The company's pipeline includes two primary drug candidates in advanced clinical stages: Sepofarsen is currently in a Phase II/III clinical trial, known as the ILLUMINATE trial, targeting Leber Congenital Amaurosis 10 (LCA10). Ultevursen is also undergoing Phase II/III evaluation for the treatment of USH2A-mediated retinitis pigmentosa and Usher syndrome. Beyond its clinical programs, ProQR is actively developing its proprietary Axiomer RNA base-editing platform technology. Strategic collaborations are central to ProQR's strategy, evidenced by its licensing agreements with institutions such as Radboud University Medical Center, Inserm Transfert SA, Ionis Pharmaceuticals, Inc., and Leiden University Medical Center. Furthermore, a significant license and research partnership exists with Eli Lilly and Company, focused on the discovery, advancement, and commercialization of novel medicines for genetic conditions impacting the liver and nervous system. Established in 2012, ProQR Therapeutics N.V. maintains its corporate headquarters in Leiden, the Netherlands.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

ProQR Therapeutics N.V. logo

ProQR Therapeutics N.V.

NASDAQ:PRQRHealthcare
-3.47%$1.39
AH$1.43+2.88%vs close
Mkt Cap$196.16M
Float118.18M
O/S141.12M
Vol
$ Vol
RVOL
Inst Own43.0%
SI2.5%
Earnings
Dilution
Financials Summary
Revenue$17.07M
Net Income-$45.27M
Total Assets$147.95M
Free Cash Flow-$60.12M
Debt & Equity
Debt 22%
Equity 78%
Total Debt$18.36M
Total Equity$64.78M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in PRQR's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$147.95M
Liabilities$83.16M
Accounts Receivable$6.67M
Accounts Payable$391K
Inventory$0
PP&E (Net)$16.57M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Revenue$17.07M$21.12M$7.28M$4.02M$1.49M$1.15M$2.16M$5.52M-$1.71M$2.55M$10.51M$350K$0
YoY Growth-19.2%190.2%81.2%169.2%29.7%-46.8%-60.9%-423.2%-167.0%-75.7%2905.4%--
Cost of Revenue$2.9M$0$0$0$0$0$130.51M$1.1M$1.12M$1.43M$539K$0$0
Gross Profit$14.17M$21.12M$7.28M$4.02M$1.49M$1.15M-$128.36M$4.42M-$2.83M$1.12M$9.97M$350K$0
Gross Margin83.0%100.0%100.0%100.0%100.0%100.0%-5943.6%80.1%165.5%43.8%94.9%100.0%-
Research and Development$45.49M$40.62M$28.1M$56.83M$47.17M$42.6M$51.94M$32.97M$34.8M$35.66M$26.14M$11.47M$2.87M
Selling, General, and Administrative$16.83M$15.26M$18.14M$20.84M$19.4M$15.29M$14.4M$14.01M$12.11M$10.59M$7.64M$7.27M$878K
Other-$1.05M-$715K-$3.36M-$855K-$1.17M-$9.41M$2.16M$6.44M$1.67M$2.04M$3.61M$0$0
Total Operating Expenses$61.26M$55.16M$42.87M$76.81M$65.41M$48.48M$66.34M$46.98M$46.91M$46.25M$33.78M$18.74M$3.62M
Operating Income (EBIT)-$47.1M-$34.04M-$35.59M-$72.8M-$63.92M-$47.33M-$64.18M-$40.55M-$45.24M-$44.21M-$30.17M-$18.39M-$3.62M
Operating Margin-275.9%-161.2%-489.1%-1813.0%-4285.4%-4117.4%-2971.8%-734.5%2648.7%-1734.1%-287.1%-5259.1%-
Interest Expense$968K$1.2M$1.34M$5.73M$3.8M$2.28M$1.21M$905K$666K$601K$441K$296K$42K
Interest Income$2.5M$3.63M$2.9M$118K$6K$350K$449K-$885K-$3.55M$525K$6.89M$4.84M$27K
Other Income (Expense)$1.85M$2.81M$4.52M$1.17M-$3.88M-$4.61M$131.44M-$885K$950K$525K$6.89M$4.84M-$16K
Income Before Tax (EBT)-$45.25M-$31.24M-$31.07M-$71.62M-$67.79M-$51.94M-$63.25M-$41.43M-$48.79M-$43.69M-$23.27M-$13.55M-$3.63M
Income Tax Expense$20K-$220K-$87K$107K$131K$139K$147K$1K$2K$0$0$0$27K
Net Income-$45.27M-$31.02M-$31.41M-$71.97M-$67.86M-$52.02M-$63.4M-$41.22M-$48.75M-$43.69M-$23.27M-$13.55M-$3.63M
Net Income Margin-265.2%-146.9%-431.7%-1792.5%-4549.8%-4525.3%-2935.6%-746.7%2854.0%-1713.5%-221.5%-3874.4%-
Supplementary Data
EPS-0.38-0.34-0.35-0.91-0.96-0.93-1.38-1.08-1.72-1.67-0.89-0.55-0.15
Diluted EPS-0.38-0.34-0.35-0.91-0.96-0.93-1.38-1.08-1.72-1.67-0.89-0.55-0.15
Weighted Average OS105.33M81.67M81.01M71.64M64.18M50.06M41.04M34.05M25.37M23.35M23.34M22.15M22.21M
EBITDA-$41.26M-$26.95M-$26.92M-$63.08M-$61.39M-$54.11M-$190.26M-$39.42M$1.19M-$40.18M-$94.12M-$55.52M-$3.56M
EBITDA Margin-241.7%-127.6%-369.9%-1571.0%-4116.0%-4707.1%-8810.2%-714.1%-69.7%-1575.9%-895.5%-15877.3%-
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Assets
Current Assets
Cash and Cash Equivalents$121.25M$172.84M$146.77M$113M$238.25M$103.67M$140.39M$134.84M$64.53M$69.76M$115.13M$152.4M$6.36M$367K
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$121.25M$172.84M$146.77M$113M$238.25M$103.67M$140.39M$134.84M$64.53M$69.76M$115.13M$152.4M$6.36M$367K
Accounts Receivable$6.67M$2.34M$1.56M$68.24M$1.05M$1.09M$1.49M$2.74M$629K$1.84M$1.82M$1.02M$199K$69K
Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Current Assets$131.37M$177.98M$149.31M$184.17M$243.28M$109.38M$143.8M$138.4M$67.83M$73.08M$118.65M$153.97M$6.56M$440K
Long-Term Assets
Property, Plant & Equipment Net$16.57M$16.33M$20.85M$19.36M$22.19M$25.43M$3.06M$2.38M$3.36M$4.05M$2.67M$1.6M$314K$0
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$52K$106K$171K$220K$60K$57K
Long-Term Investments$0$0$0$740K$799K$146K$538K$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Long-Term Assets$16.57M$16.33M$20.85M$20.1M$22.99M$25.57M$3.6M$2.38M$3.41M$4.16M$2.84M$1.83M$374K$57K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$147.95M$194.3M$170.16M$204.27M$266.27M$134.96M$147.4M$140.78M$71.24M$77.23M$121.49M$155.8M$6.93M$498K
Liabilities
Current Liabilities
Accounts Payable$391K$19K$1.9M$467K$243K$302K$558K$172K$732K$387K$1.07M$1.69M$1.15M$140K
Short-Term Debt$5.83M$5.17M$1.99M$4.63M$8.01M$3.27M$1.07M$0$2.63M$0$18K$46K$3.9M$0
Current Income Tax Payable$0$0$0$0$0$0$72K$0$1.14M$349K$263K$381K$32K$3K
Current Unearned Revenue$23.03M$25.38M$25.38M$6.73M$6.5M$957K$892K$696K$466K$0$175K$0$0$0
Other Current Liabilities$13.31M$14.44M$12.93M$13.2M$20.31M$9.54M$11.19M$9.54M$7.57M$7.51M$5.37M$2.17M$496K$71K
Total Current Liabilities$42.57M$45M$42.21M$25.02M$35.06M$14.08M$13.79M$10.42M$11.39M$7.91M$6.66M$4.07M$5.55M$211K
Long-Term Liabilities
Long-Term Debt$0$0$5.3M$5.09M$49.95M$22.13M$15.94M$8.98M$7.09M$5.42M$5.85M$3.8M$1.42M$140K
Long-Term Unearned Revenue$28.07M$34.05M$54.51M$78.18M$18.66M$0$0$0$0$0$0$0$32K$1K
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$0$0$3M$0$1.3M$0$0$0$0
Total Long-Term Liabilities$40.6M$46.85M$76.87M$99.74M$87.35M$43.58M$15.94M$11.99M$7.09M$6.71M$5.85M$3.82M$1.53M$141K
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$83.16M$91.85M$119.08M$124.77M$122.41M$57.66M$29.72M$22.41M$18.48M$14.62M$12.51M$7.9M$7.07M$352K
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$5.65M$4.98M$4.16M$4.02M$3.81M$2.96M$2.71M$2.2M$1.95M$1.1M$1.13M$1.26M$91K$49K
Retained Earnings-$613.41M-$494.16M-$494.69M-$452.02M-$403.72M-$352.33M-$265.54M-$198.52M-$160.14M-$89.24M-$44.45M-$21.36M-$5.65M-$616K
Comprehensive Income & Other$37.65M$31.93M$32.06M$36.08M$38.49M$32.69M$20.95M$13.91M$11.42M$5.11M$2.31M$929K$63K$0
Other Stockholders' Equity$672.54M$591.63M$541.62M$527.97M$544.54M$427.41M$381.13M$314.98M$210.99M$150.75M$152.3M$167.99M$5.42M$713K
Total Equity$64.78M$102.45M$51.08M$79.96M$144.62M$78.04M$118.29M$118.66M$52.81M$62.61M$108.98M$147.9M-$137K$146K
Minority Interest$0$0$0-$458K-$767K-$745K-$622K-$294K-$51K$0$0$0$0$0
Total Liabilities and Equity$147.95M$194.3M$170.16M$204.73M$267.03M$135.7M$148.02M$141.07M$71.29M$77.23M$121.49M$155.8M$6.93M$498K
Supplementary Data
Total Debt$18.36M$17.97M$24.35M$26.2M$76.7M$46.85M$17.01M$8.98M$9.72M$5.42M$5.87M$3.87M$5.4M$140K
Net Debt-$102.9M-$154.87M-$122.41M-$86.81M-$161.54M-$56.81M-$123.39M-$125.85M-$54.81M-$64.34M-$109.26M-$148.53M-$961K-$227K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Operating Activities
Net Income-$47.13M-$31.02M-$30.99M-$71.73M-$67.92M-$52.08M-$63.4M-$41.43M-$48.63M-$43.7M-$23.27M-$13.55M-$3.63M
Depreciation & Amortization$3.02M$3.08M$2.81M$2.82M$2.6M$2.63M$2.29M$1.11M$1.19M$1.39M$536K$141K$27K
Deferred Income Tax$21K-$220K-$87K$107K$131K$139K$147K$114K$162K$264K$493K$159K$15K
Stock-Based Compensation$4.48M$2.84M$3.47M$3.21M$6.94M$8.76M$10.18M$3.6M$4.5M$2.74M$1.35M$722K$46K
Changes in Working Capital:
  Accounts Receivable$0$0$0$0$0$0$0$0$0$0$0$0-$90K
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable$0$0$0$0$0$0$0$0$0$0$0$0$0
  Other Working Capital-$19.46M-$14.82M$54.69M-$5.58M$27.95M-$6.12M$1.89M$1.45M$183K$1.6M$712K$1.22M$1.02M
Total Working Capital Change-$19.46M-$14.82M$54.69M-$5.58M$27.95M-$6.12M$1.89M$1.45M$183K$1.6M$712K$1.22M$926K
Other Non-Cash Items$83K-$530K-$5.83M-$5.36M$1.24M-$5.91M-$235K$885K$3.55M-$525K-$6.89M-$4.84M$16K
Net Cash from Operating-$58.98M-$40.66M$24.07M-$76.54M-$29.06M-$52.58M-$49.12M-$34.28M-$39.05M-$38.23M-$27.07M-$16.15M-$2.61M
Investing Activities
Capital Expenditures-$1.14M-$1.58M-$1.53M-$791K-$541K-$1.03M-$648K-$349K-$135K-$2.84M-$1.48M-$1.38M-$153K
Acquisitions$0$0$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments$0-$18.99M$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$18.99M$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$0-$2.97M$6.31M$7K$66K$0$0$0$0$0-$31K$0$0
Net Cash from Investing-$1.14M-$4.55M$4.78M-$784K-$475K-$1.03M-$648K-$349K-$135K-$2.84M-$1.48M-$1.38M-$153K
Financing Activities
Debt Repaid$2.13M$1.77M$2.94M$50.33M-$29.98M-$15.38M-$1.63M-$1.56M-$1.06M-$397K-$1.79M-$1.82M-$3.72M
Common Stock Issuance$77K$80.03M$0$15.78M$121.19M$0$54.24M$94.06M$28.7M$2K$16K$132.11M$3.38M
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$249K$395K$38K$1.7M$821K$216K$972K$4K$2K$16K$0$0
Net Cash from Financing-$2.05M$78.51M-$2.54M-$34.51M$152.87M$16.2M$56.08M$99.04M$29.76M$399K$1.81M$133.93M$7.09M
Forex Effect-$1.51M$752K$669K$8.21M$1.44M-$2.94M$806K-$191K-$2.98M$824K$6.78M$4.93M$0
Net Change in Cash-$63.67M$34.06M$26.98M-$103.62M$124.78M-$40.34M$7.12M$64.22M-$12.4M-$39.84M-$19.97M$121.34M$4.33M
Supplementary Data
Operating Cash Flow-$58.98M-$40.66M$24.07M-$76.54M-$29.06M-$52.58M-$49.12M-$34.28M-$39.05M-$38.23M-$27.07M-$16.15M-$2.61M
Capital Expenditure-$1.14M-$1.58M-$1.53M-$791K-$541K-$1.03M-$648K-$349K-$135K-$2.84M-$1.48M-$1.38M-$153K
Free Cash Flow-$60.12M-$42.24M$22.54M-$77.33M-$29.6M-$53.61M-$49.77M-$34.63M-$39.18M-$41.07M-$28.55M-$17.53M-$2.76M
Cash at Beginning$166.92M$132.86M$105.88M$209.5M$84.73M$125.07M$117.95M$53.74M$66.14M$105.98M$125.95M$4.61M$278K
Cash at End$103.24M$166.92M$132.86M$105.88M$209.5M$84.73M$125.07M$117.95M$53.74M$66.14M$105.98M$125.95M$4.61M